Track topics on Twitter Track topics that are important to you
ValenTx, Inc. is developing a less-invasive, implantable medical device to address morbid obesity. The Company's founding principle was to emulate the proven mechanisms of gastric bypass surgery, but with a less invasive, implantable, and removable device. ValenTx was initially funded by leading medical technology venture capital investors, Sapient Capital, EDF Ventures, Kaiser Permanente, Affinity Capital Partners, and T-Gap Ventures. A recent fundraising was led by SV Life Sciences and also included Covidien Ventures. ValenTx is based in Carpinteria, California.
The purpose of this study is to collect clinical data to support the use of the ValenTx Endo Bypass System to improve weight loss and the resolution of comorbidities in obese subjects.
To evaluate the safety and efficacy of the endoscopically implanted ValenTx EndoPass™ System for treatment of adults with severe obesity. The EndoPass System is indicated for weight los...
ValenTx, Inc. is developing a less-invasive, implantable medical device to address morbid obesity. The Company's founding principle was to emulate the proven mechanisms of gastric bypass surgery, but ...
We have published hundreds of ValenTx, Inc. news stories on BioPortfolio along with dozens of ValenTx, Inc. Clinical Trials and PubMed Articles about ValenTx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ValenTx, Inc. Companies in our database. You can also find out about relevant ValenTx, Inc. Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...